BioSyent Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	16.57	12.11	7.98	7.86	18.04	20.29
Short-Term Investments	6.83	3.83	18.2	20.83	10.18	5.29
Cash & Short-Term Investments	23.4	15.94	26.19	28.7	28.21	25.58
Cash Growth	37.10%	-39.13%	-8.74%	1.72%	10.30%	16.40%
Accounts Receivable	6.22	2.87	3.45	3.18	2.49	1.6
Other Receivables	0.05	0.03	0.03	0.32	0.29	0.22
Receivables	6.33	2.99	3.55	3.66	3.21	1.82
Inventory	5.9	5.33	5.89	4.54	2.2	2.07
Prepaid Expenses	0.34	0.2	0.24	0.25	0.46	0.31
Other Current Assets	-	0.01	-	-	-	-
Total Current Assets	35.97	24.47	35.87	37.14	34.08	29.77
Property, Plant & Equipment	1	1.16	1.4	1.61	1.85	2.07
Long-Term Investments	5.4	10.1	2.5	-	-	-
Other Intangible Assets	4.79	4.88	1.02	1.09	0.83	0.96
Long-Term Deferred Tax Assets	0.34	0.4	0.36	0.21	0.1	0.03
Long-Term Deferred Charges	0.2	0.2	0.17	0.17	0.12	0.13
Total Assets	47.79	41.36	41.53	40.49	37.17	33.57
Accounts Payable	6.41	4	5.08	5.06	3.56	3.72
Current Portion of Leases	0.21	0.2	0.18	0.17	0.16	0.15
Current Income Taxes Payable	0.31	0.4	0.11	0.32	0.1	0.25
Current Unearned Revenue	0.16	0.81	0.13	0.16	0.31	0.93
Other Current Liabilities	0.02	-	0.03	-	-	0.08
Total Current Liabilities	7.11	5.41	5.53	5.72	4.14	5.14
Long-Term Leases	0.68	0.84	1.04	1.22	1.4	1.56
Long-Term Deferred Tax Liabilities	0.09	0.11	0.2	0.18	0.08	0.08
Total Liabilities	7.88	6.36	6.77	7.12	5.61	6.78
Common Stock	5.24	5.31	5.12	5.37	5.8	6.39
Additional Paid-In Capital	2.01	2.14	2.29	2.23	1.82	1.49
Retained Earnings	32.82	27.73	27.53	25.91	24.12	19.08
Comprehensive Income & Other	-0.17	-0.17	-0.18	-0.14	-0.19	-0.17
Shareholders' Equity	39.9	35	34.76	33.36	31.55	26.8
Total Liabilities & Equity	47.79	41.36	41.53	40.49	37.17	33.57
Total Debt	0.89	1.04	1.22	1.4	1.56	1.71
Net Cash (Debt)	22.5	14.9	24.97	27.3	26.65	23.87
Net Cash Growth	40.81%	-40.31%	-8.55%	2.42%	11.67%	18.63%
Net Cash Per Share	1.95	1.26	2.05	2.18	2.07	1.82
Filing Date Shares Outstanding	11.26	11.26	11.61	12.1	12.41	12.74
Total Common Shares Outstanding	11.26	11.28	11.74	12.1	12.56	12.81
Working Capital	28.86	19.07	30.34	31.42	29.94	24.64
Book Value Per Share	3.54	3.10	2.96	2.76	2.51	2.09
Tangible Book Value	35.11	30.13	33.74	32.27	30.72	25.83
Tangible Book Value Per Share	3.12	2.67	2.87	2.67	2.45	2.02
Machinery	0.97	0.95	0.91	0.85	0.81	0.75
Leasehold Improvements	0.68	0.68	0.68	0.68	0.68	0.68

Source: S&P Global Market Intelligence. Standard template. Financial Sources.